Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Sanofi-aventis and Chattem, Sanofi-aventis’ US Consumer Healthcare Division, have received US Food and Drug Administration (FDA) approval for over-the-counter (OTC) use of Allegra (fexofenadine HCl) family of allergy drug in adults and children two years of age and older.
Subscribe to our email newsletter
The company will launch the allergy drug in the US as an OTC in March 2011.
Sanofi-aventis Global Operations president Hanspeter Spek said leveraging their US Consumer Healthcare platform to convert prescription medicines to OTC products is a key growth driver for Sanofi-aventis to become a diversified healthcare company also in the US.
"The approval of Allegra for OTC use in the US further validates our vision to increase our presence in the US consumer healthcare market," Spek said.